CH621544A5 - - Google Patents

Download PDF

Info

Publication number
CH621544A5
CH621544A5 CH922276A CH922276A CH621544A5 CH 621544 A5 CH621544 A5 CH 621544A5 CH 922276 A CH922276 A CH 922276A CH 922276 A CH922276 A CH 922276A CH 621544 A5 CH621544 A5 CH 621544A5
Authority
CH
Switzerland
Prior art keywords
formula
fluoropyrimidine
mixture
reaction
compound
Prior art date
Application number
CH922276A
Other languages
German (de)
English (en)
Inventor
Mitugi Yasumoto
Junichi Yamashita
Ichiro Yamawaki
Norio Unemi
Kenji Kitazato
Sadao Hashimoto
Setsuro Fujii
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50150936A external-priority patent/JPS6011032B2/ja
Priority claimed from JP15093775A external-priority patent/JPS6011033B2/ja
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of CH621544A5 publication Critical patent/CH621544A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH922276A 1975-12-16 1976-07-19 CH621544A5 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50150936A JPS6011032B2 (ja) 1975-12-16 1975-12-16 2―置換―5―フルオルピリミジン―4―オン誘導体の製造法
JP15093775A JPS6011033B2 (ja) 1975-12-16 1975-12-16 5‐フルオルピリミジン―4―オン誘導体の製造法

Publications (1)

Publication Number Publication Date
CH621544A5 true CH621544A5 (nl) 1981-02-13

Family

ID=26480366

Family Applications (2)

Application Number Title Priority Date Filing Date
CH922276A CH621544A5 (nl) 1975-12-16 1976-07-19
CH629080A CH625230A5 (nl) 1975-12-16 1980-08-20

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH629080A CH625230A5 (nl) 1975-12-16 1980-08-20

Country Status (12)

Country Link
US (1) US4080455A (nl)
AU (1) AU505440B2 (nl)
CA (1) CA1063606A (nl)
CH (2) CH621544A5 (nl)
DE (1) DE2633359C3 (nl)
DK (1) DK137957B (nl)
FI (1) FI61885C (nl)
FR (1) FR2335228A1 (nl)
GB (1) GB1501537A (nl)
NL (1) NL162643C (nl)
NO (1) NO143903C (nl)
SE (1) SE439159B (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68935B (nl) * 1976-03-31 1982-03-29 Takeda Chemical Industries Ltd
JPS5446791A (en) * 1977-09-22 1979-04-12 Takeda Chem Ind Ltd Fluorouracil derivative
US4343940A (en) * 1979-02-13 1982-08-10 Mead Johnson & Company Anti-tumor quinazoline compounds
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
CN101955465B (zh) * 2010-09-29 2012-07-04 浙江工业大学 一种5-氟嘧啶-4(3h)-酮类化合物及其制备方法和应用
CN102532039B (zh) * 2010-09-29 2014-03-26 浙江工业大学 一种5-氟嘧啶-4(3h)-酮类化合物在制备抗肿瘤药物中的应用
CN102659689B (zh) * 2012-05-16 2014-12-17 浙江工业大学 4-取代-2-丁氧基-5-氟嘧啶类化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802005A (en) * 1957-08-06 S-eluorourace
US3784693A (en) * 1972-10-18 1974-01-08 Sandoz Ag 3-substituted phenyl-quinazoline-4(3h)-ones as sedative hypnotics
CH579057A5 (nl) * 1973-09-07 1976-08-31 Hoffmann La Roche

Also Published As

Publication number Publication date
FI762166A (nl) 1977-06-17
DE2633359B2 (de) 1980-12-04
DK137957B (da) 1978-06-12
SE7608306L (sv) 1977-06-17
DE2633359C3 (de) 1981-12-17
NL162643C (nl) 1980-06-16
DE2633359A1 (de) 1977-06-30
SE439159B (sv) 1985-06-03
NL7608537A (nl) 1977-06-20
FI61885C (fi) 1982-10-11
FR2335228B1 (nl) 1978-11-17
CA1063606A (en) 1979-10-02
AU505440B2 (en) 1979-11-22
FI61885B (fi) 1982-06-30
GB1501537A (en) 1978-02-15
AU1547576A (en) 1978-01-05
DK137957C (nl) 1978-11-06
NL162643B (nl) 1980-01-15
FR2335228A1 (fr) 1977-07-15
CH625230A5 (nl) 1981-09-15
NO762664L (nl) 1977-06-17
DK346176A (nl) 1977-06-17
NO143903B (no) 1981-01-26
NO143903C (no) 1981-05-06
US4080455A (en) 1978-03-21

Similar Documents

Publication Publication Date Title
DE1445176B2 (de) Verfahren zur herstellung von 2,4-diamino-5-benzyl-pyrimidinen
DE3010040A1 (de) Verfahren zur gewinnung von rosmarinsaeure aus melisse
DE1620694C3 (de) Verfahren zur Herstellung von 5-Methyl-7-diäthylamino-s-triazolo [1,5-a] pyrimidin und seinen Salzen mit Säuren
EP0354246A1 (de) 3'-Azido-2',3'-dideoxynucleosid-5'-phosphonate
CH621544A5 (nl)
DE2323746A1 (de) Mono- und diester der 2,5-dihydroxybenzolsulfonsaeure
DE2928594C2 (de) 3-Hydroxy-4-(hydroxymethyl)-benzoesäure, deren Salze, Hydrate und Hydratsalze, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
CH467277A (de) Verfahren zur Herstellung von Cobalticorrinoiden
DE2065698C3 (de) Verfahren zur Herstellung von 2-Isopropyl-6-methyl-4(3H)-pyrimidon
AT356118B (de) Verfahren zur herstellung neuer 5- -fluorpyrimidin-4-on-derivate
DE3888694T2 (de) Isoprenoid-derivate und arzneimittelzubereitung, die diese enthält.
DE2650366C3 (de) Verwendung eines 5-Fluoruracilde-
DE2345060C3 (de) 1,2-Dialkylketonglycerin-3-phosphatide und Verfahren zu deren Herstellung
DE2455026A1 (de) Therapeutisches mittel
DE1593832C3 (de) Verfahren zur Herstellung von Calcium DL Pantothenat
AT355046B (de) Verfahren zur herstellung von neuen 5-fluor- dihydrouracilen
DE2003840A1 (de) 3-Phenyl-4-acyloxycarbostyrile,Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
AT365164B (de) Verfahren zur herstellung des neuen pivaloyloxymethyl-2-propylpentanoats
DE2443401A1 (de) Neue aliphatisch substituierte arylchalkogeno-kohlenwasserstoffderivate und verfahren zu ihrer herstellung
DE2043174C3 (de) Zimtsäurederivate
DE2648239B2 (de) Di-(trialkylstannyl)-pyrimidinderivate, Verfahren zu ihrer Herstellung und Verfahren zu ihrer Weiterverarbeitung zu nucleosidartigen Pyrimidinderivaten
EP0478721B1 (de) Neue benzocycloalkencarbonsäure und verfahren zu ihrer herstellung
DE3306505C2 (de) 4-Desmethoxy-13-dihydro-daunorubicin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
DE1768142C (de) Verfahren zur Herstellung von Herzglykosidderivaten und Arzneimittel
DE1643615B2 (de) Cytostatisch wirksames Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased